Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation - Brennan, SO; Mosesson, MW; Lowen, R (Thromb Haemost, 2006)